Avantor Cost of Goods Sold 2018-2024 | AVTR

Avantor annual/quarterly cost of goods sold history and growth rate from 2018 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Avantor cost of goods sold for the quarter ending September 30, 2024 was $1.150B, a 0.74% increase year-over-year.
  • Avantor cost of goods sold for the twelve months ending September 30, 2024 was $4.533B, a 2.13% decline year-over-year.
  • Avantor annual cost of goods sold for 2023 was $4.603B, a 6.24% decline from 2022.
  • Avantor annual cost of goods sold for 2022 was $4.91B, a 0.54% increase from 2021.
  • Avantor annual cost of goods sold for 2021 was $4.883B, a 13.22% increase from 2020.
Avantor Annual Cost of Goods Sold
(Millions of US $)
2023 $4,603
2022 $4,910
2021 $4,883
2020 $4,313
2019 $4,120
2018 $4,045
2017 $815
Avantor Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $1,150
2024-06-30 $1,121
2024-03-31 $1,109
2023-12-31 $1,152
2023-09-30 $1,142
2023-06-30 $1,154
2023-03-31 $1,156
2022-12-31 $1,181
2022-09-30 $1,206
2022-06-30 $1,263
2022-03-31 $1,261
2021-12-31 $1,260
2021-09-30 $1,218
2021-06-30 $1,232
2021-03-31 $1,173
2020-12-31 $1,209
2020-09-30 $1,099
2020-06-30 $988
2020-03-31 $1,017
2019-12-31 $1,044
2019-09-30 $1,030
2019-06-30 $1,041
2019-03-31 $1,005
2018-12-31
2018-09-30 $1,016
2018-06-30 $1,010
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $14.831B $6.967B
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $95.766B 11.88
Cencora (COR) United States $49.023B 18.08
DiDi Global (DIDIY) China $23.330B 0.00
ICON (ICLR) Ireland $17.511B 15.60
Natera (NTRA) United States $16.712B 0.00
Viatris (VTRS) United States $15.433B 4.75
Revvity (RVTY) United States $14.647B 25.44
BioMerieux (BMXMF) France $12.894B 0.00
CochLear (CHEOY) Australia $12.739B 0.00
Solventum (SOLV) United States $12.214B 0.00
Medpace Holdings (MEDP) United States $11.215B 31.59
Charles River Laboratories (CRL) United States $11.042B 21.34
Doximity (DOCS) United States $10.778B 63.79
HealthEquity (HQY) United States $8.750B 47.49
Sonic Healthcare (SKHHY) Australia $8.450B 0.00
Bausch + Lomb (BLCO) Canada $6.881B 32.03
Life Times (LTH) United States $5.005B 33.12
Sotera Health (SHC) United States $4.402B 23.55
Organon (OGN) United States $4.012B 4.05
Surgery Partners (SGRY) United States $3.759B 42.85
BrightSpring Health Services (BTSG) United States $3.402B 72.37
PACS (PACS) United States $3.129B 0.00
Concentras Parent (CON) United States $2.579B 0.00
Alignment Healthcare (ALHC) United States $2.523B 0.00
Ardent Health Partners (ARDT) United States $2.446B 0.00
Premier (PINC) United States $2.301B 11.48
GeneDx Holdings (WGS) United States $2.113B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GoodRx Holdings (GDRX) United States $1.783B 47.00
Teladoc Health (TDOC) United States $1.670B 0.00
Progyny (PGNY) United States $1.551B 29.62
Pediatrix Medical (MD) United States $1.331B 13.02
CareDx (CDNA) United States $1.251B 0.00
Establishment Labs Holdings (ESTA) $1.184B 0.00
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Embecta (EMBC) United States $0.898B 5.99
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
InnovAge Holding (INNV) United States $0.778B 0.00
Agilon Health (AGL) United States $0.770B 0.00
SBC Medicals (SBC) United States $0.717B 0.00
Auna S.A (AUNA) Luxembourg $0.510B 0.00
Sonida Senior Living (SNDA) United States $0.442B 0.00
DocGo (DCGO) United States $0.426B 16.00
Enhabit (EHAB) United States $0.383B 33.09
COMPASS Pathways (CMPS) United Kingdom $0.346B 0.00
LifeMD (LFMD) United States $0.310B 0.00
ModivCare (MODV) United States $0.244B 13.24
Sera Prognostics (SERA) United States $0.242B 0.00
Beauty Health (SKIN) United States $0.211B 0.00
Nutex Health (NUTX) United States $0.204B 0.00
Biodesix (BDSX) United States $0.204B 0.00
MultiPlan (MPLN) United States $0.141B 0.00
Ascend Wellness Holdings (AAWH) United States $0.120B 0.00
So-Young (SY) China $0.073B 17.77
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.051B 0.00
NeueHealth (NEUE) United States $0.042B 1.12
Co-Diagnostics (CODX) United States $0.037B 0.00
Pheton Holdings (PTHL) China $0.029B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
IceCure Medical (ICCM) Israel $0.027B 0.00
Oncology Institute (TOI) United States $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00